Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Vultaggio

Showing results (21-30 of 137) with videos related to

Pageof 14
Sort By:
Frontiers in Immunology|November 18, 2021
How to Prevent and Mitigate Hypersensitivity Reactions to Biologicals Induced by Anti-Drug Antibodies?Alessandra Vultaggio, Margherita Perlato, Francesca Nencini, et al.
Expert Review of Clinical Pharmacology|May 21, 2020
Immunogenicity-unwanted immune responses to biological drugs - can we predict them?Andrea Matucci, Francesca Nencini, Emanuele Vivarelli, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|August 24, 2023
"Patient remodeling" as a consequence of uncontrolled and prolonged OCS use in severe asthma: how biologic therapy can reverse a dangerous trendMargherita Perlato, Valentina Mecheri, Emanuele Vivarelli, et al.
Plos One|April 17, 2015
High serum β-lactams specific/total IgE ratio is associated with immediate reactions to β-lactams antibioticsAlessandra Vultaggio, Gianni Virgili, Francesco Gaeta, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 10, 2022
Rituximab and infliximab desensitization with anti-IgE mAb omalizumab as adjuvant therapy: a case seriesMargherita Perlato, Valentina Mecheri, Matteo Accinno, et al.
Frontiers in Pharmacology|January 11, 2021
Mechanisms of Drug Desensitization: Not Only Mast CellsAlessandra Vultaggio, Andrea Matucci, Francesca Nencini, et al.
Expert Review of Clinical Immunology|December 14, 2011
Asthma: developments in targeted therapyAndrea Matucci, Alessandra Vultaggio, Erminia Ridolo, et al.
Clinical and Molecular Allergy : CMA|March 27, 2019
Rapid clinical improvement of atopic dermatitis in an Omalizumab treated patientSusanna Bormioli, Andrea Matucci, Laura Dies, et al.
International Journal of Molecular Sciences|April 3, 2021
Asthma and Chronic Rhinosinusitis: How Similar Are They in Pathogenesis and Treatment Responses?Andrea Matucci, Susanna Bormioli, Francesca Nencini, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 3, 2019
The percentage of patients achieving complete remission of urticaria increases with repeated courses of treatmentAndrea Matucci, Francesca Nencini, Oliviero Rossi, et al.
Pageof 14

Showing results (21-30 of 137) with videos related to

Sort By:
Pageof 14
Frontiers in Immunology|November 18, 2021
How to Prevent and Mitigate Hypersensitivity Reactions to Biologicals Induced by Anti-Drug Antibodies?Alessandra Vultaggio, Margherita Perlato, Francesca Nencini, et al.
Expert Review of Clinical Pharmacology|May 21, 2020
Immunogenicity-unwanted immune responses to biological drugs - can we predict them?Andrea Matucci, Francesca Nencini, Emanuele Vivarelli, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|August 24, 2023
"Patient remodeling" as a consequence of uncontrolled and prolonged OCS use in severe asthma: how biologic therapy can reverse a dangerous trendMargherita Perlato, Valentina Mecheri, Emanuele Vivarelli, et al.
Plos One|April 17, 2015
High serum β-lactams specific/total IgE ratio is associated with immediate reactions to β-lactams antibioticsAlessandra Vultaggio, Gianni Virgili, Francesco Gaeta, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 10, 2022
Rituximab and infliximab desensitization with anti-IgE mAb omalizumab as adjuvant therapy: a case seriesMargherita Perlato, Valentina Mecheri, Matteo Accinno, et al.
Frontiers in Pharmacology|January 11, 2021
Mechanisms of Drug Desensitization: Not Only Mast CellsAlessandra Vultaggio, Andrea Matucci, Francesca Nencini, et al.
Expert Review of Clinical Immunology|December 14, 2011
Asthma: developments in targeted therapyAndrea Matucci, Alessandra Vultaggio, Erminia Ridolo, et al.
Clinical and Molecular Allergy : CMA|March 27, 2019
Rapid clinical improvement of atopic dermatitis in an Omalizumab treated patientSusanna Bormioli, Andrea Matucci, Laura Dies, et al.
International Journal of Molecular Sciences|April 3, 2021
Asthma and Chronic Rhinosinusitis: How Similar Are They in Pathogenesis and Treatment Responses?Andrea Matucci, Susanna Bormioli, Francesca Nencini, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 3, 2019
The percentage of patients achieving complete remission of urticaria increases with repeated courses of treatmentAndrea Matucci, Francesca Nencini, Oliviero Rossi, et al.
Pageof 14